Scientific Programme
15–17 April 2027 | Grand Hotel Union, Ljubljana
The programme includes a basic bone marrow pathology course, lecture sessions and interactive workshops. A major emphasis will be put on highlighting the advances in molecular pathogenesis and its relation to diagnosis, prognosis, and treatment.
1. Myeloproliferative conditions at the diagnostic interface between myeloproliferative neoplasms and non-neoplastic proliferations
Triple negative cases (JAK2, CALR and MPL negative) are particularly welcome. Cases associated with germline variants, as well as cases of hereditary or secondary polycythemia, are excluded.
2. AML and MDS with emerging disease-defining genetic alterations
Cases harboring genetic alterations with potential disease-defining significance that are not yet recognized as defining entities in current classification systems (ICC 2022 and WHO 5th edition), e.g., UBTF-TD, der(1;7), and SETBP1 mutations.
3. Mature large B-cell lymphomas with primary presentation in bone or exclusive involvement of the bone marrow
The focus is on mature large B-cell and/or high-grade lymphomas presenting primarily in bone or exclusively in the bone marrow. Follicular lymphomas are excluded.
Bone marrow pathology essentials for trainees and general pathologists seeking to strengthen their diagnostic skills.
State-of-the-art presentations by internationally renowned experts covering the latest classifications and research advances.
Case-based discussions led by the expert panel. We encourage attendees to submit interesting cases for review.
All lectures will be streamed live and made available on demand. Registered participants will receive a link for streaming all recordings for a 3-month period after the conference.